TrialClinical pharmacokinetics2022

Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients.

David Busse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.